{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["L-type calcium channel", "carbonic anhydrase", "dodoneine", "molecular diversity", "superacid"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28561785", "DateCompleted": {"Year": "2018", "Month": "03", "Day": "12"}, "DateRevised": {"Year": "2018", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "05", "Day": "31"}], "Language": ["eng"], "ELocationID": ["915", "10.3390/molecules22060915"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "22", "Issue": "6", "PubDate": {"Year": "2017", "Month": "May", "Day": "31"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Bioactive Natural Product and Superacid Chemistry for Lead Compound Identification: A Case Study of Selective hCA III and L-Type Ca<sup>2+</sup> Current Inhibitors for Hypotensive Agent Discovery.", "Abstract": {"AbstractText": ["Dodoneine (Ddn) is one of the active compounds identified from <i>Agelanthus</i><i>dodoneifolius</i>, which is a medicinal plant used in African pharmacopeia and traditional medicine for the treatment of hypertension. In the context of a scientific program aiming at discovering new hypotensive agents through the original combination of natural product discovery and superacid chemistry diversification, and after evidencing dodoneine's vasorelaxant effect on rat aorta, superacid modifications allowed us to generate original analogues which showed selective human carbonic anhydrase III (hCA III) and L-type Ca<sup>2+</sup> current inhibition. These derivatives can now be considered as new lead compounds for vasorelaxant therapeutics targeting these two proteins."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Superacid Group/Organic Synthesis Team, Universit\u00e9 de Poitiers, IC2MP-UMR CNRS 7285, 86073 Poitiers CEDEX 09, France. helene.carreyre@univ-poitiers.fr."}], "LastName": "Carreyre", "ForeName": "H\u00e9l\u00e8ne", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "STIM-ERL CNRS 7368 Universit\u00e9 de Poitiers, 86073 Poitiers Cedex 9, France. gregoire.carre@etu.univ-poitiers.fr."}], "LastName": "Carr\u00e9", "ForeName": "Gr\u00e9goire", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoire de Physiologie Animale, Universit\u00e9 de Ouagadougou, 03 BP 7021 Ouagadougou 01, Burkina Faso. clarisse.vandebrouck@univ-poitiers.fr."}], "LastName": "Ouedraogo", "ForeName": "Maurice", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "STIM-ERL CNRS 7368 Universit\u00e9 de Poitiers, 86073 Poitiers Cedex 9, France. jocelyn.bescond@univ-poitiers.fr."}], "LastName": "Vandebrouck", "ForeName": "Clarisse", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "STIM-ERL CNRS 7368 Universit\u00e9 de Poitiers, 86073 Poitiers Cedex 9, France. ouedraogo_maurice@yahoo.fr."}], "LastName": "Bescond", "ForeName": "Jocelyn", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurofarba, Sez, Chimica Farmaceutica e Nutraceutica, University of Florence, 50019 Sesto Fiorentino, Italy. claudiu.supuran@unifi.it."}], "LastName": "Supuran", "ForeName": "Claudiu T", "Initials": "CT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Superacid Group/Organic Synthesis Team, Universit\u00e9 de Poitiers, IC2MP-UMR CNRS 7285, 86073 Poitiers CEDEX 09, France. claudiu.supuran@unifi.it."}], "LastName": "Thibaudeau", "ForeName": "S\u00e9bastien", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antihypertensive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Calcium Channels, L-Type"}, {"RegistryNumber": "0", "NameOfSubstance": "Carbonic Anhydrase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenols"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyrones"}, {"RegistryNumber": "0", "NameOfSubstance": "Vasodilator Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "dodoneine"}, {"RegistryNumber": "EC 4.2.1.-", "NameOfSubstance": "Carbonic Anhydrase III"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antihypertensive Agents"}, {"QualifierName": ["drug effects", "metabolism", "physiopathology"], "DescriptorName": "Aorta"}, {"QualifierName": [], "DescriptorName": "Biological Products"}, {"QualifierName": ["drug effects"], "DescriptorName": "Blood Pressure"}, {"QualifierName": ["metabolism"], "DescriptorName": "Calcium Channels, L-Type"}, {"QualifierName": ["metabolism"], "DescriptorName": "Carbonic Anhydrase III"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Carbonic Anhydrase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism", "physiopathology"], "DescriptorName": "Hypertension"}, {"QualifierName": ["chemistry"], "DescriptorName": "Loranthaceae"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Phenols"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Pyrones"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Tissue Culture Techniques"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Vasodilator Agents"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Munos B. Lessons from 60 years of pharmaceutical innovation. Nat. Rev. Drug Discov. 2009;8:959\u2013968. doi: 10.1038/nrd2961.", "ArticleIdList": ["10.1038/nrd2961", "19949401"]}, {"Citation": "Scannel J.W., Blanckley A., Boldon H., Warrington B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 2012;11:191\u2013200. doi: 10.1038/nrd3681.", "ArticleIdList": ["10.1038/nrd3681", "22378269"]}, {"Citation": "Walsh G. Pharmaceutical Biotechnology. Wiley; Chichester, UK: 2007."}, {"Citation": "Ziegler S., Pries V., Hedberg C., Waldmann H. Target identification for small bioactive molecules: Finding the needle in the haystack. Angew. Chem. Int. Ed. 2013;52:2744\u20132792. doi: 10.1002/anie.201208749.", "ArticleIdList": ["10.1002/anie.201208749", "23418026"]}, {"Citation": "Scott D.E., Bayly A.R., Skidmore J. Small molecules, big targets: Drug discovery faces the protein-protein interaction challenge. Nat. Rev. Drug Discov. 2016;15:533\u2013550. doi: 10.1038/nrd.2016.29.", "ArticleIdList": ["10.1038/nrd.2016.29", "27050677"]}, {"Citation": "Adams J.L., Smothers J., Srinivasan R., Hoos A. Big opportunities for small molecules in immuno-oncology. Nat. Rev. Drug Discov. 2015;14:603\u2013622. doi: 10.1038/nrd4596.", "ArticleIdList": ["10.1038/nrd4596", "26228631"]}, {"Citation": "Foley D.J., Nelson A., Marsden S.P. Evaluating New Chemistry to Drive Molecular Discovery: Fit for Purpose? Angew. Chem. Int. Ed. 2016;55:13650\u201313657. doi: 10.1002/anie.201604193.", "ArticleIdList": ["10.1002/anie.201604193", "PMC5113762", "27573303"]}, {"Citation": "Abet V., Mariani A., Truscott F.R., Britton S., Rodriguez R. Biased and Unbiased Strategies to Identify Biologically Active Small Molecules. Bioorg. Med. Chem. 2014;22:4474\u20134489. doi: 10.1016/j.bmc.2014.04.019.", "ArticleIdList": ["10.1016/j.bmc.2014.04.019", "24811300"]}, {"Citation": "Cusack K.P., Koolman H.F., Lange U.E.W., Peltier H.M., Piel I., Vasudevan A. Emerging Technologies for Metabolite Generation and Structural Diversification. Bioorg. Med. Chem. Lett. 2013;23:5471\u20135483. doi: 10.1016/j.bmcl.2013.08.003.", "ArticleIdList": ["10.1016/j.bmcl.2013.08.003", "23992859"]}, {"Citation": "Hert J., Irwin J.J., Laggner C., Keiser M.J., Shoichet B.K. Quantifying Biogenic Bias in Screening Libraries. Nat. Chem. Biol. 2009;5:479\u2013483. doi: 10.1038/nchembio.180.", "ArticleIdList": ["10.1038/nchembio.180", "PMC2783405", "19483698"]}, {"Citation": "Brown D.G., Bostr\u00f6m J. Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone? J. Med. Chem. 2016;59:4443\u20134458. doi: 10.1021/acs.jmedchem.5b01409.", "ArticleIdList": ["10.1021/acs.jmedchem.5b01409", "26571338"]}, {"Citation": "Li J.W.H., Vederas J.C. Drug Discovery and Natural Products: End of an Era or an Endless Frontier? Science. 2009;235:161\u2013165. doi: 10.1126/science.1168243.", "ArticleIdList": ["10.1126/science.1168243", "19589993"]}, {"Citation": "Harvey A.L., Edrada-Ebel R.U., Quinn R.J. The Re-Emergence of Natural Products for Drug Discovery in Genomics Era. Nat. Rev. Drug Discov. 2015;14:111\u2013129. doi: 10.1038/nrd4510.", "ArticleIdList": ["10.1038/nrd4510", "25614221"]}, {"Citation": "Butler M.S., Robertson A.A.B., Cooper M.A. Natural products and natural products derived drugs in clinical trials. Nat. Prod. Rep. 2014;31:1612\u20131661. doi: 10.1039/C4NP00064A.", "ArticleIdList": ["10.1039/C4NP00064A", "25204227"]}, {"Citation": "Newman D.J., Cragg G.M. Natural Products as Sources of New Drugs over the 30 Years from 1981 to 2010. J. Nat. Prod. 2012;75:311\u2013335. doi: 10.1021/np200906s.", "ArticleIdList": ["10.1021/np200906s", "PMC3721181", "22316239"]}, {"Citation": "Drewry D.H., Macarron R. Enhancements of Screening Collections to Address Areas of Unmet Medical Need: An Industry Perspective. Curr. Opin. Chem. Biol. 2010;14:289\u2013298. doi: 10.1016/j.cbpa.2010.03.024.", "ArticleIdList": ["10.1016/j.cbpa.2010.03.024", "20413343"]}, {"Citation": "Sukuru S.C., Jenkins J.L., Scheiber J., Bender A., Mikhailov D., Davies J.W., Glick M. Plate-based Diversity Selection Based on Empirical HTS Data to Enhance the Number of Hits and their Chemical Diversity. J. Biomol. Screen. 2009;14:690\u2013699. doi: 10.1177/1087057109335678.", "ArticleIdList": ["10.1177/1087057109335678", "19531667"]}, {"Citation": "DeCorte B.L. Underexplored Opportunities for Natural Products in Drug Discovery. J. Med. Chem. 2016;59:9295\u20139304. doi: 10.1021/acs.jmedchem.6b00473.", "ArticleIdList": ["10.1021/acs.jmedchem.6b00473", "27331414"]}, {"Citation": "Robles O., Romo D. Chemo- and site-selective derivatizations of natural products enabling biological studies. Nat. Prod. Rep. 2014;31:318\u2013334. doi: 10.1039/c3np70087a.", "ArticleIdList": ["10.1039/c3np70087a", "PMC4041598", "24468713"]}, {"Citation": "Cernak T., Dykstra K.D., Tyagarajan S., Petr Vachalb P., Krskab S.W. The medicinal chemist\u2019s toolbox for late stage functionalization of drug-like molecules. Chem. Soc. Rev. 2016;45:546\u2013576. doi: 10.1039/C5CS00628G.", "ArticleIdList": ["10.1039/C5CS00628G", "26507237"]}, {"Citation": "Durak L.J., Payne J.T., Lewis J.C. Late-Stage Diversification of Biologically Active Molecules via Chemoenzymatic C\u2013H Functionalization. ACS Catal. 2016;6:1451\u20131454. doi: 10.1021/acscatal.5b02558.", "ArticleIdList": ["10.1021/acscatal.5b02558", "PMC4890977", "27274902"]}, {"Citation": "Olah G.A., Prakash G.K.S., Molnar A., Sommer J. Superacids. 2nd ed. Wiley; New York, NY, USA: 2009."}, {"Citation": "Olah G.A., Klumpp D. Superelectrophiles and Their Chemistry. Wiley; New York, NY, USA: 2008."}, {"Citation": "Jacquesy J.C. Organic Synthesis in Superacids. In: Olah G.A., editor. Carbocation Chemistry. Wiley; New York, NY, USA: 2004. pp. 359\u2013376."}, {"Citation": "Jacquesy J.C. Natural Product Chemistry in Superacids. In: Olah G.A., editor. Stable Carbocation Chemistry. Wiley; New York, NY, USA: 1997. pp. 549\u2013574."}, {"Citation": "Fahy J., Duflos A., Ribert J.-P., Jacquesy J.-C., Berrier C., Jouannetaud M.-P., Zunino F. Vinca Alkaloids in Superacidic Media: A Method for Creating a New Family of Antitumor Derivatives. J. Am. Chem. Soc. 1997;119:8576\u20138577. doi: 10.1021/ja971864w.", "ArticleIdList": ["10.1021/ja971864w"]}, {"Citation": "Kearney P.M., Whelton M., Reynolds K., Munter P., Whelton P.K., He J. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005;365:217\u2013223. doi: 10.1016/S0140-6736(05)70151-3.", "ArticleIdList": ["10.1016/S0140-6736(05)70151-3", "15652604"]}, {"Citation": "Ibrahim M.M., Damasceno A. Hypertension in developing countries. Lancet. 2012;380:611\u2013619. doi: 10.1016/S0140-6736(12)60861-7.", "ArticleIdList": ["10.1016/S0140-6736(12)60861-7", "22883510"]}, {"Citation": "Ouedraogo S., Traor\u00e9 A., Som\u00e9 N., Lompo M., Guissou P.I., Schott C., Bucher B., Andriantsitohaina R. Cardiovascular properties of aqueous extract from Tapinanthus dodoneifolius DC Danser. Afr. J. Trad. Complement. Altern. Med. 2005;2:25\u201330. doi: 10.4314/ajtcam.v2i1.31101.", "ArticleIdList": ["10.4314/ajtcam.v2i1.31101"]}, {"Citation": "Ouedraogo M., Carreyre H., Vandebrouck C., Bescond J., Raymond G., Guissou I.-P., Cognard C., Becq F., Potreau D., Cousson A., et al. Structure Elucidation of a Dihydropyranone from Tapinanthus dodoneifolius. J. Nat. Prod. 2007;70:2006\u20132009. doi: 10.1021/np070355x.", "ArticleIdList": ["10.1021/np070355x", "18052322"]}, {"Citation": "Ouedraogo M., Ruiz M., Vardelle E., Carreyre H., Coustard J.M., Potreau D., Sawadogo L.L., Cognard C., Becq F., Vandebrouck C., et al. From the vasodilator and hypotensive effects of an extract fraction from Agelanthus dodoneifolius (DC) Danser (Loranthaceae) to the active coumpound dodoneine. J. Ethnopharmacol. 2011;133:345\u2013352. doi: 10.1016/j.jep.2010.10.002.", "ArticleIdList": ["10.1016/j.jep.2010.10.002", "20937377"]}, {"Citation": "Carr\u00e9 G., Carreyre H., Ouedraogo M., Becq F., Bois P., Thibaudeau S., Vandebrouck C., Bescond J. The hypotensive agent dodoneine inhibits L-type calcium current with negative inotropic effect on rat heart. Eur. J. Pharmacol. 2014;728:119\u2013127. doi: 10.1016/j.ejphar.2014.01.059.", "ArticleIdList": ["10.1016/j.ejphar.2014.01.059", "24508520"]}, {"Citation": "Calhoun D.A., Jones D., Textor S., Goff D.C., Murphy T.P., Toto R.D., White A., Cushman W.C., White W., Sica D., et al. Resistant hypertension: Diagnosis, evaluation and treatment: A scientific statement from the American Heart Association Professional Educational Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510\u2013e526. doi: 10.1161/CIRCULATIONAHA.108.189141.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.108.189141", "18574054"]}, {"Citation": "Baker E.H. Ion channels and the control of blood pressure. Br. J. Clin. Pharmacol. 2000;49:185\u2013192. doi: 10.1046/j.1365-2125.2000.00159.x.", "ArticleIdList": ["10.1046/j.1365-2125.2000.00159.x", "PMC2014909", "10718773"]}, {"Citation": "Carr\u00e9 G., Ouedraogo M., Magaud C., Carreyre C., Becq F., Bois P., Supuran C.T., Thibaudeau S., Vandebrouck C., Bescond J. Vasorelaxation induced by dodoneine is mediated by calcium channel blockade and carbonic anhydrase inhibition on vascular smooth muscle cells. J. Ethnopharmacol. 2015;169:8\u201317. doi: 10.1016/j.jep.2015.03.037.", "ArticleIdList": ["10.1016/j.jep.2015.03.037", "25847623"]}, {"Citation": "Opie L.H., Yusuf S., Kubler W. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: A critical analysis based on 100 studies. Prog. Cardiovasc. Dis. 2000;43:171\u2013196. doi: 10.1053/pcad.2000.7010.", "ArticleIdList": ["10.1053/pcad.2000.7010", "11014332"]}, {"Citation": "Swenson E.R. New Insights into Carbonic Anhydrase Inhibition, Vasodilation, and Treatment of Hypertensive-Related Diseases. Curr. Hypertens. Rep. 2014;16:467\u2013478. doi: 10.1007/s11906-014-0467-3.", "ArticleIdList": ["10.1007/s11906-014-0467-3", "25079851"]}, {"Citation": "Pickkers P., Garcha R.S., Schachter M., Smits P., Hugues A.D. Inhibition of Carbonic Anhydrase Accounts for the Direct Vascular Effects of Hydrochlorothiazide. Hypertension. 1999;33:1043\u20131048. doi: 10.1161/01.HYP.33.4.1043.", "ArticleIdList": ["10.1161/01.HYP.33.4.1043", "10205245"]}, {"Citation": "Alvarez B.V., Johnson D.E., Sowah D., Soliman D., Light P.E., Xia Y., Karmazyn M., Casey J.R. Carbonic anhydrase inhibition prevents and reverts cardiomyocyte hypertrophy. J. Physiol. 2007;579:127\u2013145. doi: 10.1113/jphysiol.2006.123638.", "ArticleIdList": ["10.1113/jphysiol.2006.123638", "PMC2075384", "17124262"]}, {"Citation": "Krishnamurthy V.M., Kaufman G.K., Urbach A.R., Gitlin I., Gudiksen K.L., Weibel D.B., Whitesides G.M. Carbonic Anhydrase as a Model for Biophysical and Physical-Organic Studies of Proteins and Protein\u2212Ligand. Chem. Rev. 2008;108:946\u20131051. doi: 10.1021/cr050262p.", "ArticleIdList": ["10.1021/cr050262p", "PMC2740730", "18335973"]}, {"Citation": "Supuran C.T. Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators. Nat. Rev. Drug Dis. 2008;7:168\u2013181. doi: 10.1038/nrd2467.", "ArticleIdList": ["10.1038/nrd2467", "18167490"]}, {"Citation": "Supuran C.T. Carbonic Anhydrases as Drug Targets: General Presentation. In: Supuran C.T., Winum J.Y., editors. Drug Design of Zinc-Enzyme. Wiley; Hoboken, NJ, USA: 2009. pp. 15\u201338."}, {"Citation": "Alterio V., Di Fiore A., D\u2019Ambrosio K., Supuran C.T., De Simone G. Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms? Chem. Rev. 2012;112:4421\u20134468. doi: 10.1021/cr200176r.", "ArticleIdList": ["10.1021/cr200176r", "22607219"]}, {"Citation": "Supuran C.T. How many carbonic anhydrase inhibition mechanisms exist? J. Enzym. Inhib. Med. Chem. 2016;31:345\u2013360. doi: 10.3109/14756366.2015.1122001.", "ArticleIdList": ["10.3109/14756366.2015.1122001", "26619898"]}, {"Citation": "Maresca A., Temperini C., Vu H., Pham N.B., Poulsen S.A., Scozzafava A., Quinn R.J., Supuran C.T. Non-Zinc Mediated Inhibition of Carbonic Anhydrases: Coumarins Are a New Class of Suicide Inhibitors. J. Am. Chem. Soc. 2009;131:3057\u20133062. doi: 10.1021/ja809683v.", "ArticleIdList": ["10.1021/ja809683v", "19206230"]}, {"Citation": "Maresca A., Temperini C., Pochet L., Masereel B., Scozzafava A., Supuran C.T. Deciphering the Mechanism of Carbonic Anhydrase Inhibition with Coumarins and Thiocoumarins. J. Med. Chem. 2010;53:335\u2013344. doi: 10.1021/jm901287j.", "ArticleIdList": ["10.1021/jm901287j", "19911821"]}, {"Citation": "Carta F., Maresca A., Scozzafava A., Supuran C.T. Novel Coumarins and 2-Thioxo-Coumarins as Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII. Bioorg. Med. Chem. 2012;20:2266\u20132273. doi: 10.1016/j.bmc.2012.02.014.", "ArticleIdList": ["10.1016/j.bmc.2012.02.014", "22377674"]}, {"Citation": "Tars K., Vullo D., Kazaks A., Leitans J., Lends A., Grandane A., Zalubovskis R., Scozzafava A., Supuran C.T. Sulfocoumarins (1,2-Benzoxathiine-2,2-dioxides): A Class of Potent and Isoform-Selective Inhibitors of Tumor-Associated Carbonic Anhydrases. J. Med. Chem. 2013;56:293\u2013300. doi: 10.1021/jm301625s.", "ArticleIdList": ["10.1021/jm301625s", "23241068"]}, {"Citation": "Durdagi S., Sent\u00fcrk M., Ekinci D., Balaydin H.T., Innocenti A., Scozzafava A., Supuran C.T. Kinetic and Docking Studies of Phenol-Based Inhibitors of Carbonic Anhydrase Isoforms I, II, IX and XII Evidence a New Binding Mode Within the Enzyme Active Site. Bioorg. Med. Chem. 2011;19:1381\u20131389. doi: 10.1016/j.bmc.2011.01.016.", "ArticleIdList": ["10.1016/j.bmc.2011.01.016", "21282059"]}, {"Citation": "Carta F., Maresca A., Scozzafava A., Supuran C.T. 5- and 6-Membered (Thio)Lactones Are Prodrug Type Carbonic Anhydrase Inhibitors. Bioorg. Med. Chem. Lett. 2012;22:267\u2013270. doi: 10.1016/j.bmcl.2011.11.018.", "ArticleIdList": ["10.1016/j.bmcl.2011.11.018", "22137345"]}, {"Citation": "Nair S.K., Ludwig P.A., Christianson D.W. Two-Site Binding of Phenol in the Active Site of Human Carbonic Anhydrase II: Structural Implications for Substrate Association. J. Am. Chem. Soc. 1994;116:3659\u20133660. doi: 10.1021/ja00087a086.", "ArticleIdList": ["10.1021/ja00087a086"]}, {"Citation": "Davis R.A., Hohmann A., Osman A., Hall R.A., M\u00fchlschlegel F.A., Vullo D., Innocenti A., Supuran C.T., Poulsen S.A. Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases. J. Med. Chem. 2001;54:1682\u20131692. doi: 10.1021/jm1013242.", "ArticleIdList": ["10.1021/jm1013242", "21332115"]}, {"Citation": "Khalifah R.G. The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. J. Biol. Chem. 1971;246:2561\u20132573.", "ArticleIdList": ["4994926"]}, {"Citation": "Berg J.T., Ramanathan S., Gabrielli M.G., Swenson E.R. Carbonic Anhydrase in Mammalian Vascular Smooth Muscle. J. Histichem. Cytochem. 2004;52:1101\u20131106. doi: 10.1369/jhc.4A6266.2004.", "ArticleIdList": ["10.1369/jhc.4A6266.2004", "15258186"]}, {"Citation": "O\u2019Hagan D. Understanding organofluorine chemistry. An introduction to the C-F bond. Chem. Soc. Rev. 2008;37:308\u2013319. doi: 10.1039/B711844A.", "ArticleIdList": ["10.1039/B711844A", "18197347"]}, {"Citation": "Gouverneur V., Seppelt K. Introduction: Fluorine chemistry. Chem. Rev. 2015;115:563\u2013565. doi: 10.1021/cr500686k.", "ArticleIdList": ["10.1021/cr500686k", "25627818"]}, {"Citation": "Gillis E.P., Eastman K.J., Hill M.D., Donnelly D.J., Meanwell N.A. Applications of fluorine in medicinal chemistry. J. Med. Chem. 2015;58:8315\u20138359. doi: 10.1021/acs.jmedchem.5b00258.", "ArticleIdList": ["10.1021/acs.jmedchem.5b00258", "26200936"]}, {"Citation": "Thibaudeau S., Carreyre H., Mingot A. Synthesis of fluorinated nitrogen-containing compounds through superelectrophilic activation in superacid HF/SbF5. In: Groult H., Leroux F., Tressaud A., editors. Modern Synthesis Process and Reactivity of Fluorinated Compounds. Elsevier; Paris, France: 2017. pp. 349\u2013388.", "ArticleIdList": ["10.1016/B978-0-12-803740-9.00013-5"]}, {"Citation": "Bonazaba Milandou L.J.C., Carreyre H., Alazet S., Greco G., Martin-Mingot A., Nkounkou Loumpangou C., Ouamba J.-M., Bouazza F., Billard T., et al. Superacid-catalyzed trifluoromethylthiolation of aromatic amines. Angew. Chem. Int. Ed. 2017;56:169\u2013172. doi: 10.1002/anie.201609574.", "ArticleIdList": ["10.1002/anie.201609574", "27891747"]}, {"Citation": "M\u00e9tayer B., Mingot A., Vullo D., Supuran C.T., Thibaudeau S. New superacid synthesized (fluorinated) tertiary benzenesulfonamides acting as selective hCA IX inhibitors: Toward a new mode of carbonic anhydrase inhibition by sulfonamides. Chem. Commun. 2013;49:6015\u20136017. doi: 10.1039/c3cc40858b.", "ArticleIdList": ["10.1039/c3cc40858b", "23503420"]}, {"Citation": "M\u00e9tayer B., Compain G., Jouvin K., Martin-Mingot A., Bachmann C., Marrot J., Evano G., Thibaudeau S. Chemo- and stereoselective synthesis of fluorinated enamides from ynamides in HF/pyridine: Second-generation approach to potent urea bioisosteres. J. Org. Chem. 2015;80:3397\u20133410. doi: 10.1021/jo502699y.", "ArticleIdList": ["10.1021/jo502699y", "25569215"]}, {"Citation": "Le Darz A., Mingot A., Bouazza F., Castelli U., Karam O., Tanc M., Supuran C.T., Thibaudeau S. Fluorinated pyrrolidines and piperidines incorporating tertiary benzenesulfonamide moieties are selective carbonic anhydrase II inhibitors. J. Enzym. Inhib. Med. Chem. 2015;5:737\u2013745. doi: 10.3109/14756366.2014.963072.", "ArticleIdList": ["10.3109/14756366.2014.963072", "25431145"]}, {"Citation": "Carreyre H., Coustard J-M., Carr\u00e9 G., Vandebrouck C., Bescond J., Ouedraogo M., Marrot J., Vullo D., Supuran C.T., Thibaudeau S. Natural product hybrid and its superacid synthesized analogues: Dodoneine and its derivatives show selective inhibition of carbonic anhydrase isoforms I, III, XIII and XIV. Bioorg. Med. Chem. 2013;21:3790\u20133794. doi: 10.1016/j.bmc.2013.04.041.", "ArticleIdList": ["10.1016/j.bmc.2013.04.041", "23685174"]}]}], "History": [{"Year": "2017", "Month": "5", "Day": "9"}, {"Year": "2017", "Month": "5", "Day": "23"}, {"Year": "2017", "Month": "5", "Day": "23"}, {"Year": "2017", "Month": "6", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "3", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "5", "Day": "31"}], "PublicationStatus": "epublish", "ArticleIdList": ["28561785", "PMC6152723", "10.3390/molecules22060915", "molecules22060915"]}}]}